Skip to main content
. 2021 Jan 27;13(2):385. doi: 10.3390/nu13020385

Figure 2.

Figure 2

Percentage of patients with G1–4 diarrhoea and G3–4 diarrhoea receiving chemotherapy treatment with capecitabine or 5-fluorouracil (5-FU).